Table 2.
Univariate and multivariate survival analyses of the ARMCX family.
| Items | Cases (total n = 351) | No. of events (%) | MST (days) | Crude P | Crude HR (95% CI) | Adjusted P | Adjusted HR (95% CI) |
|---|---|---|---|---|---|---|---|
| ARMCX1 | |||||||
| Low | 175 | 61 (34.6%) | 1294 | 0.016 | 0.667 (0.479-0.929) | 0.006 | 0.620 (0.440-0.874) |
| High | 176 | 83 (47.6%) | 766 | Ref. | Ref. | ||
| ARMCX2 | |||||||
| Low | 176 | 58 (33.0%) | 1686 | 0.012 | 0.655 (0.469-0.915) | 0.005 | 0.610 (0.432-0.861) |
| High | 175 | 86 (49.1%) | 762 | Ref. | Ref. | ||
| ARMCX3 | |||||||
| Low | 176 | 66 (37.5%) | 1095 | 0.366 | Ref. | 0.690 | Ref. |
| High | 175 | 78 (44.6%) | 794 | 1.163 (0.838-1.616) | 1.072 (0.763-1.506) | ||
| ARMCX4 | |||||||
| Lo | 176 | 70 (39.8%) | 1095 | 0.570 | Ref. | 0.220 | Ref. |
| High | 175 | 74 (42.3%) | 801 | 1.099 (0.793-1.525) | 1.238 (0.880-1.741) | ||
| ARMCX5 | |||||||
| Low | 176 | 76 (43.2%) | 728 | 0.271 | Ref. | 0.507 | Ref. |
| High | 175 | 68 (38.9%) | 1153 | 0832 (0.599-1.155) | 0.891 (0.634-1.253) | ||
| ARMCX6 | |||||||
| Low | 176 | 73 (41.5%) | 1153 | 0.786 | Ref. | 0.929 | Ref. |
| High | 175 | 71 (40.6%) | 874 | 0.956 (0.689-1.326) | 1.016 (0.722-1.428) |
Abbreviations: MST: median survival time; Ref.: reference; HR: hazard ratio; 95% CI: 95% confidence interval; Notes: Adjusted P, adjustment for age and tumor stage.